Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06268041 · ClinicalTrials.gov registry record · NA
HIT-Stroke Trial 2
A NA study of Stroke, sponsored by University of Cincinnati.
- Recruiting
- Registry status
- NA
- Development phase
- 156
- Enrollment target
- 3
- Study locations
NCT06268041: Recruiting NA study of Stroke, sponsored by University of Cincinnati.
NCT06268041 is a NA study of Stroke that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 156 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06268041, a NA study of Stroke, is actively recruiting participants, sponsored by University of Cincinnati.
- RECRUITING
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
- 3
- Study locations
Study Summary
People who had a stroke at least 6 months prior and who still have difficulty with walking will each be randomly assigned to receive either moderate or vigorous intensity walking exercise. Both protocols will be performed individually with a physical therapist for 45 minutes, 3x/week for 12 weeks. Measures including walking function will be assessed at baseline (PRE), after 4, 8 and 12 weeks of training (12WK) and at 3-month follow up (3moPOST), by raters who are unaware of the participant randomization.
Primary Outcome
Total distance walked in 6 minutes in meters
Conditions Studied
Interventions
- BEHAVIORAL High-Intensity Interval Training
- BEHAVIORAL Moderate-Intensity Aerobic Training
Study Locations (3)
Delaware
- University of Delaware - Newark
Kansas
- University of Kansas Medical Center - Kansas City
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2024-02-09 |
| Est. Completion | 2028-04 |
| Phase | NA |
What NCT06268041 shows while recruiting
NCT06268041 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which High-Intensity Interval Training is the first listed.
NCT06268041 reports a single indexed study location in Delaware, Kansas, Ohio.
Frequently Asked Questions
What is clinical trial NCT06268041 about?
NCT06268041 is a clinical study titled "HIT-Stroke Trial 2". People who had a stroke at least 6 months prior and who still have difficulty with walking will each be randomly assigned to receive either moderate or vigorous intensity walking exercise. Both protocols will be performed individually with a physical therapist for 45 minutes, 3x/week for 12 weeks. M...
What is the current status of trial NCT06268041?
This trial is currently recruiting. It is a NA study. The enrollment target is 156 participants. The study started on 2024-02-09. Estimated completion is 2028-04.
What conditions does trial NCT06268041 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT06268041?
The interventions under investigation include: High-Intensity Interval Training (BEHAVIORAL), Moderate-Intensity Aerobic Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06268041?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06268041 being conducted?
This trial has 3 study locations across Delaware, Kansas, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06268041's enrollment target sits among peer trials
156 104th of 454 higher than 351 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI